Pomalidomide enhances CD8+ T and NK cell mediated killing of HIV-infected cells
This study was supported by grants from the National Health and Medical Research Council of Australia (NHMRC), The Australian Centre for HIV and Hepatitis Research (ACH4), the Melbourne HIV Cure Consortium, J & M Wright Foundation, Australia, and the Independent Research Fund, Denmark.
Authors
- Alexander D. Barrow (ORCID: https://orcid.org/0000-0001-5833-0537)
- Thomas A. Rasmussen (ORCID: https://orcid.org/0000-0001-5354-2442)
- Rachel D. Pascoe (ORCID: https://orcid.org/0000-0001-7707-1972)
- Daniel T. Utzschneider (ORCID: https://orcid.org/0000-0003-2205-9057)
- Chris Chiu (ORCID: https://orcid.org/0000-0002-5380-1114)
- Jenny L. Anderson (ORCID: https://orcid.org/0000-0003-4636-6633)
- Céline Gubser (ORCID: https://orcid.org/0000-0002-3588-3814)
- Sharon R. Lewin (ORCID: https://orcid.org/0000-0002-0330-8241)
- Wen Shi Lee (ORCID: https://orcid.org/0000-0001-7285-4054)
- Jan Schroeder (ORCID: https://orcid.org/0000-0001-5270-0605)
- James McMahon (ORCID: https://orcid.org/0000-0003-1460-5572)
- Ajantha Solomon
- J. Judy Chang
Institutions
- The University of Melbourne (AU)
- The Alfred Hospital (AU)
- Aarhus University Hospital (DK)
- Monash Alfred Psychiatry Research centre (AU)
- Peter Doherty Institute (AU)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1016/j.ebiom.2025.106004
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00